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A large number and variety of compounds are formed in the process of chlorinating drinking water.
The classes of compounds formed include trihalomethanes, haloacetic acids, haloacetonitriles, halophe-
nols, and halopropanones. Many of the compounds have been shown to be toxic and are currently being
further evaluated by the U.S. Environmental Protection Agency (EPA).
One group of the halopropanones found in chlorinated drinking water is the dichloropropanones. The
toxicological properties of this group have not been well characterized. In addition, a number of inves-
tigators have shown that ketones potentiate the hepatotoxicity of haloalkanes. We conducted a series of
studies to explore both the toxicity ofthe dichloropropanones and their potential interactions with a well-
characterized haloalkane, carbon tetrachloride. Avariety oftoxicological and biochemical endpoints were
used to evaluate the toxicity of the dichloropropanones and their interaction with CCI4, including cyto-
chrome P-450 concentration, reduced glutathione levels, pentane generation, serum enzymeactivities, and
histopathology.
Administration of 1,1-dichloropropanone (DCP) resulted in elevated serum enzymes associated with
periportal necrosis. Glutathione levels were reduced by the administration of1,1-DCP; pentanegeneration
was not increased. When 1,1-DCP was given prior to CC14, the data were consistent with additivity.
Administration of1,3-DCPdidnotresult inelevatedserumenzymes, norwastherehistopathologicevidence
of necrosis. Glutathione levels and pentane generation in the 1,3-DCP-treated groups were the same as
those ofcontrols. Inhibition ofthe toxicologic effects ofCCl4 in adose-related mannerwas observed when
1,3-DCP was administered prior to CCl4.
Introduction
Since Rook (1) demonstrated the formation of chlo-
roform and other chlorobrominated methanes resulting
from the chlorination of water containing humic sub-
stancesandinorganicbromine, anumberofstudieshave
confirmed and elaborated on the formation of halocom-
pounds as by-products of the chlorination process (2-
6). The classes of halogenated compounds that are
formed include acids, alcohols, hydrocarbons (aromatic
and nonaromatic), ketones, and aldehydes (5).
One group ofketones that is formed, but that has not
been investigated toxicologically, is the dichloropropa-
nones (DCP) (also known as dichloroacetones). Since
many ofthe short-chained hydrocarbon contaminants of
drinking water are known hepatotoxins (e.g., halome-
thanes), one purpose ofthese studies was to collect hep-
atotoxicity data on 1,1-dichloro-2-propanone (1,1-DCP)
and 1,3-dichloro-2-propanone (1,3-DCP).
Itiswellrecognized thataliphatic alcohols and carbon
tetrachloride (CC14) interact (7-14). Reports in the lit-
erature also indicate that ketones and CC14 interact and
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that ketones and chloroform interact as well (16-19).
Because the DCPs are ketones, a second purpose for
conducting these studies was to examine the interac-
tions between the DCPs and CC14.
Methods
CD-1 mice were used in these experiments and were
obtained from Charles River (Portage, MI), held for a
one-week quarantine period, and randomlyhoused, five
per plastic cage, on hardwood chip bedding (Absorb-
Dri, St. Regis Paper, Garfield, NJ). Purina Lab Chow
and distilled water that had been carbon filtered and
irradiated with ultraviolet light were available ad lib-
itum. The room in which the animals were housed was
maintained at 20-22°C with 40-60% relative humidity
and 12-hr interval light-dark cycles. Doses ofCCl4 (re-
agent grade, Allied Chemical, Morristown, NJ) and/or
1,1-DCP (Aldrich, Milwaukee, WI) were administered
using paraffin oil (Fisher Scientific, Fairlawn, NJ) as
the vehicle, in constant volumes of 0.1 mL/10 g body
weight. 1,3-DCP was administered in distilled water at
the same constant volumes. Doses of CC14 used in the
interaction studies were selected based on preliminary
experiments indicatingthatthe effects were observableLAURIE ETAL.
and were in the beginning portion ofthe dose-response
curve. The high doses of 1,1- and 1,3-DCP were the
maximally tolerated doses.
For serum enzyme determinations, blood samples
were collected by heart puncture from the right ven-
tricle immediately after anesthesia with sodium pen-
tobarbital (Nembutal). The blood was allowed to clot
and then was centrifuged in a Beckman tabletop cen-
trifuge (TJ-6) at 2400 g. Pasteur pipettes were used to
transfer the sera to small vials that were then frozen
at -70°C. At the termination of the study, serum en-
zyme activities (alanine aminotransferase [ALT], as-
partate aminotransferase [AST], and lactate dehydro-
genase [LDH]) were measured during contiguous runs
using a CentrifiChem-400 high-speed centrifugalkinetic
analyzer (Baker Instruments) and using identical re-
agent batches and controls. For quality control, all an-
alytical runs included Dade Monitrol I and Monitrol II
control sera.
To determine the level ofin vivo pentane generation
caused by a particular compound, the method ofFrank
et al. (20) was modified. Three fasted, male mice were
gavaged with the appropriate dose ofthe compound(s)
ofinterest and then immediately placed into a 500-cm3,
oxygen-flushed desiccator. Sodalime, located inthebot-
tom ofthe desiccator, removed respired carbon dioxide.
The absorbed carbon dioxide was replaced by oxygen,
available from a Mylar bag that was attached to the
desiccator by tygon tubing. After the mice were in the
closed system for 2 hr, two aliquots of air were taken
using 10-cm3 gas-tight syringes. These samples were
theninjected into aFinnigan gas chromatograph (model
9503). The temperatures of the injector, the n-octane/
Porasil-C column (6 ft in length), and the flame ioniza-
tion detector were 50°C, 22°C (room temperature), and
150°C, respectively. Gas flow rates were: helium, 25
cm3/min; hydrogen, 30 cm3/min; air 150 cm3/min. The
standard curve was generated by evaporating a specific
amount of liquid pentane in a known volume of room
air. This stock pentane-air mixture was shaken, and
aliquots ofthe gas were removed and placed in a second
syrinne having a total volume of 10 cm3. The resulting
10-cm mixtures were injected into the gas chromato-
graph. The data consisted of integrated values of the
pentane peak.
Cytochrome P-450 was measured (24 hr after dosing)
in microsomes (protein concentration was approxi-
mately 5-10 mg/mL) obtained by centrifuging the su-
pernatant from an 8000g-for-10-min spin for 1 hr at
105,000g. Using a double-beam spectrophotometer, 0.5
mL of microsomal suspension was diluted with 3.0 mL
of a 0.05 M phosphate buffer (pH 7.4 at 22°C), a few
crystals of sodium dithionite were added, and carbon
monoxide was used to slowly gas the mixture for three
minutes. The blank cuvette consisted ofthe diluted mi-
crosomal suspension.
The glutathione (GSH) assay was a modification of
Hissin and Hilfs (21) photofluorometric methodology.
After cervical dislocation, each experimental animal
was perfused, via left ventricular heart puncture, with
cold saline. The whole liver was weighed, trimmed to
a 1-g piece, and then homogenized in a 0.1 M sodium
phosphate-0.005 M ethylenediaminetetraacetic acid
(EDTA) buffer at a pH of 8.0 at 37°C. After removing
an aliquot for protein determination (Bio-Rad Standard
Protein Assay, Richmond, CA), 25% m-phosphoric acid
(m-PA) was added to precipitate proteins. The precip-
itate was then pelleted by centrifuging at 2500g for 10
min. The supernatant (0.05 mL) was diluted with 4.95
mL of the phosphate EDTA buffer. In a cuvette, 0.1
mL ofthis dilution was added to 1.8 mL buffer. Fifteen
minutes after the addition of0.1 mL o-phthalaldehyde,
the fluorescence was measured at 420 nM after exci-
tation at 350 nM. If mitochondrial levels of GSH were
determined, a Sorvall RC-5B Refrigerated Superspeed
centrifuge, with an SS-34 rotor, was used at 500g for
10 min to pellet the nuclear debris and unbroken cells.
Subsequently, thesupernatantwascentrifuged at2500g
for 13 min. This mitochondrial pellet was resuspended
in buffer and centrifuged a second time. The pellet was
resuspended and an aliquot of the suspension was re-
moved for protein determination. Protein was precipi-
tated from the remainder of the sample by addition of
m-PA, and processing was continued as previously de-
scribed.
Experimental data were entered into and analyzed
by the Statistical Analysis System (SAS Institute,
Cary, NC). One-way analysis ofvariance (ANOVA) for
each parameter that had equal variance between treat-
ment groups and normal distribution was conducted to
test the null hypothesis that there was no response dif-
ference between groups. When the results of the AN-
OVA indicated an effect (p < 0.05), Tukey's multiple
comparison test was used to detect differences (p <
0.05) between treatment groups. Forparameters ofun-
equal variances, nonparametric tests were applied
(Kruskal-Wallis), and the medians were reported.
Results
Serum Enzyme Activities
The median values are reported in Tables 1 and 2
because as the enzyme values increased, so did the var-
iances. Therefore, the appropriate statistical analysis
was nonparametric (Kruskal-Wallis). Table 1 contains
medianenzymevaluesformiceexposedto 1,1-DCPand/
or CCl4. 1,1-DCP, when administered as above, caused
an elevation in AST, ALT, and LDH at a dose of 0.25
mL/kg. As expected, CCl4, when administered as
above, caused a dose-related increase in all the mea-
sured enzymes. The data forthe interaction of1,1-DCP
and CCl4 are consistent with additive toxicity.
Table 2 contains median enzyme values for mice ex-
posed to 1,3-DCP and/or CC14. No dose of1,3-DCP (ad-
ministered alone) in these acute studies caused an in-
crease in AST, ALT, or LDH. A dose of 0.02 mL/kg
CCl4 consistently caused an increase in the three en-
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Table 1. Clinical chemistry values (medians) for 1, 1-DCP
and/or CCl4.
Dose
1,1-DCP, CC14, AST, ALT, LDH,
mL/kg mL/kg IU/L IU/L IU/L
Experiment 1
0.00 0.00 70Ab 10A 490A
0.01 0.00 80A 1OA 420A
0.05 0.00 100A 10A 415A
0.10 0.00 75A 25A 325A
0.25 0.00 2670 CD 2590 BC 2575 B
0.00 0.02 610 B 1500 B 3460 B
0.10 0.02 2105 BC 5255 CD 10105 BC
0.25 0.02 5280 D 7560 D 12465 C
Experiment 2
0.00 0.00 60A 20A 345A
0.10 0.00 60A 30A 405A
0.00 0.01 75A 20A 355A
0.00 0.02 580 B 2300 B 4025 B
0.10 0.01 60A 20A 330A
0.10 0.02 380 B 1340 B 2605 B
aBoth 1, 1-DCP and CC14 were administered separately in pariffin
oil (0.1 mL/10 g body weight) by oral gavage. 1,1-DCP was given
approximately 4 hr before CCl4. The mice were sacrificed 24 hr after
the 1,1-DCP dose was administered.
bMedians with the same letter (within the same experiment) are
not statistically different. Significant differences (p<0.05) were de-
termined by a Kruskal-Wallis test because variances were unequal.
N = 12 for each group.
zymes. The datafortheinteraction of1,3-DCPand CC14
appear to represent an antagonistic interaction forboth
experiments in that it caused a statistically significant,
dose-related decrease in all the serum enzyme eleva-
tions normally associated with the 0.02 mL/kg dose of
CC14.
Table 2. Clinical chemistry values for 1,3-DCP and/or CCl1.
Dose
1,3-DCP, CC14, AST, ALT, LDH,
g/kg mL/kg IU/L IU/L IU/L NC
Experiment 1
0.00 0.00 60Ab 20A 475A 12
0.01 0.00 60A 30AB 340A 11
0.02 0.00 60A 40 B 380A 11
0.00 0.02 5360 C 8210 D 25580 C 12
0.01 0.02 2750 C 6465 D 21615 C 12
0.02 0.02 275 B 1385 C 3715 B 11
Experiment 2
0.00 0.00 60A 25A 355A 10
0.00 0.02 1030 C 3330 C 4955 B 10
0.01 0.02 335 BC 1770 B 3730 B 10
0.02 0.02 130A 340AB 1O90AB 7
aBoth 1,3-DCP and CC14 were administered separately in paraffin
oil (0.1 mL/10 g body weight) by oral gavage. 1,3-DCP was given
approximately 4 hr before CC14. The mice were sacrificed 24 hr after
the 1,3-DCP dose was administered.
'Medians with the same letter (within the same experiment) are
not statistically different. Significant differences (p<0.05) were de-
termined by a Kruskal-Wallis test because variances were unequal.
cThe starting N for each group in experiment 1 was 12 and in
experiment 2 was 10. The deaths in the 1,3-DCP groups were caused
by the compound, not the gavaging technique.
Table 3. Pentane generation values for 1,1-DCP, 1-3-DCP,
and/or CCI4.
Dose
1,1-DCP, 1,3-DCP, CC14, Pentane,
mL/kg g/kg mL/kg nmole/kg/hr N
5AAb 12
0.1 OA 5
0.25 0.00 0.0 1A 5
0.01 - OA 4
0.02 - OA 3
0.2 18A 5
0.5 26A 5
1.0 20 B 15
0.1 0.2 12A 5
0.1 0.5 11A 5
0.1 1.0 40 B 6
0.01 1.0 OA 7
0.02 1.0 5A 6
al,1-DCP and CC14 were administered separatelyin paraffin oil(0.1
mL/10 g body weight). 1,3-DCP was administered in distilled water.
All mice were dosedbyoralgavage. The DCPsweregiven2hrbefore
CCL4 administration.
bMedians with the same letter are not statistically different. Sig-
nificant differences (p<0.05) were determined by a Kruskal-Wallis
test.
Pentane Generation
Table 3 contains the pentane generation results of
various combinations of 1,1-DCP, 1,3-DCP, and CCl4.
Very little pentanewas generated in eithercontrol, 1,1-
DCP- or 1,3-DCP-treated mice. The groups of animals
exposed to CC14 showed an increase in the amount of
pentane produced. However, the magnitude ofthis in-
crease was not dose dependent, and neither 1,1-DCP
nor 1,3-DCP caused pentane production in this exper-
imental set-up. 1,3-DCPhadaninhibitoryeffectonCCl4
toxicity, as determined by pentane generation, in that
pentane levels returned to control levels. These data
support the clinical chemistry results.
Histology
No significant differences were observed between
control mice and those exposed to 1,3-DCP. The mice
exposed to 1,1-DCP showed evidence of periportal ne-
crosis (a large number of dead hepatocytes around the
portal triads). This condition was observed only in mice
exposed to 0.25 mL/kg. The mice exposed to CC14
showed the expected signs of centrilobular necrosis (a
large number of dead hepatocytes around the central
vein). The lowest dose at which centrilobular necrosis
was observed was 0.02 mL/kg.
In relation to the interaction studies between 1,1-
DCP and CC14, both periportal and centrilobular necro-
sis was noted when 0.25 mL/kg 1,1-DCP was adminis-
tered. The pathology report indicated that the results
ofthe 1,3-DCP and CC14 interaction suggested that the
"centrilobular necrosis may be slightly more severe in
groups without 1,3-DCP than in the groups with 1,3-
DCP."
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Table 4. Cytochrome P450 values for 1,1-DCP, 1,3-DCP, and/or
CC14.a
Dose P-450,
1,1-DCP 1,3-DCP CC14 nmole/g protein N
1.12 ± 0.05Ab 24
- - 0.01 0.98 ± 0.12AB 12
-- 0.02 0.76 ± 0.08 B 9
- - 0.05 0.42 ± 0.05 C 6
1.00 0.26 ± 0.08 C 6
0.10 - 0.89 ± 0.08 B 6
0.25 - 1.06 ± 0.04A 6
0.01 1.20 ± 0.07A 6
0.02 - 1.05 ± 0.1OA 6
0.1 - 0.01 1.07 ± 0.08A 6
0.1 0.02 1.09 ± 0.15A 6
0.02 0.02 0.69 ± 0.13 B 5
a,1-DCP and CC14were administered separatelyinparaffinoil (0.1
mL/10 g body weight). 1,3-DCP was administered in distilled water.
Allmice were dosedbyoralgavage. The DCPsweregiven2hrbefore
CC14 administration.
bMedians with the same letter are not statistically different. Sig-
nificant differences (p<0.05) were determined by a Kruskal-Wallis
test.
Cytochrome P-450
Table 4 contains data on the cytochrome P450 levels
associated with various combinations of 1,1-DCP, 1,3-
DCP, and CC14. A dose-related decrease inP-450 levels
was observed in CCl4-exposed mice. Neither 1,1-DCP
nor 1,3-DCP affected the concentrations of P-450. In
addition, neither 1,1-DCP nor 1,3-DCP appeared to in-
teract with CC14.
GSH
Table 5 contains data on the GSH concentrations as
associated with 1,1-DCP, 1,3-DCP, and CC14 adminis-
tration. The onlycompound that significantly decreased
the GSH concentration was 1,1-DCP.
Discussion
During determinations of the appropriate doses of
1,1-DCP and 1,3-DCP to administer when measuring
the effects ofthese compounds on serum enzyme activ-
ities, it became clear that each was, by definition, very
to extremely toxic (the LD50 of 1,1-DCP was 250 mg/
kg and the LD50 of1,3-DCP was 25 mg/kg; unpublished
data). This finding is of interest because the LD50 for
mice exposed to 2-propanone has ranged from 4000 to
8000 mg/kg (23) (slightly to moderately toxic). There-
fore, chlorination of2-propanone dramatically increases
its toxicity.
Althoughchlorinationmakes2-propanone moretoxic,
the locations of the two chlorine substituents are im-
portant to the type of toxicity observed. No liver tox-
icity was associated with 1,3-DCP. However, 1,1-DCP
was hepatotoxic as indicated by both clinical chemistry
evaluations and histopathology. Serum enzymes, indic-
ative of necrotic cells, were elevated. The histopatho-
logical analysis ofliver sections indicated periportal ne-
crosis associated with exposure to the 1,1-DCP isomer.
The other parameter affected by 1,1-DCP, but not by
1,3-DCP, was the level of GSH, which was decreased.
The necrosis caused by 1,1-DCP was not observed until
1,1-DCP reduced GSH to 30% of control levels. GSH
serves animportantroleintheliver as adefenseagainst
chemicals binding to cellular macromolecules (24). For
example, Thor et al. (25) showed that bromobenzene
toxicity dramatically increased when GSH levels were
decreased by prior treatment with diethyl maleate.
Therefore, the necrotic effect of 1,1-DCP seems to be
blocked by GSH until GSH is reduced to a level that is
no longer protective. It does not appear that 1,1-DCP
causes the necrosis as a result oflipid peroxidation (as
evidenced by the lack of pentane production).
The toxicologic relationship between 1,1-DCP and
CC14 is additive. The prior depletion of GSH by 1,1-
DCP would not be expected to cause a synergistic in-
Table 5. Effects of 1,1-DCP, 1,3-DCP, or CC14 treatments on glutathione levels in hepatic homogenates and subcellular fractions of
male mice.'
GSH levels
Whole Mitochondrial Postmitochondrial
homogenate fraction, fraction,
Treatment Dosage, mL/kg N (mg/g liver) ,ug/mg protein ,g/mg protein
1,1-DCP 0 12 1.80 ± 0.11 4.52 ± 0.55 14.5 ± 1.32
0.01 6 1.72 ± 0.22 4.32 ± 0.47 16.9 ± 1.87
0.05 5 1.45 ± 0.13 4.79 ± 0.90 11.6 ± 2.32
0.1 6 1.17 ± 0.09" 4.66 ± 0.76 8.0 ± 1.09
0.25 6 0.56 ± 0.10b 0.90 ± 0.25b 3.8 ± 0.52b
1,3-DCP 0.01 5 1.87 ± 0.39 4.70 ± 0.97
0.02 8 1.78 ± 0.24 4.47 ± 0.60
CC14 0 12 1.46 ± 0.17 4.51 ± 0.87 14.0 ± 2.06
0.2 6 1.16 ± 0.21 3.21 ± 0.95 11.2 ± 3.37
0.5 6 1.43 ± 0.25 3.18 ± 0.44 15.1 ± 3.05
1.0 6 1.73 ± 0.15 2.65 ± 0.27 19.4 ± 2.25
2.0 6 1.25 ± 0.22 3.31 ± 1.07 13.2 ± 3.60
a Both DCA and CC14-were administered separately in paraffin oil (0.1 mL/10 g body weight) by oral gavage 2 hr before sacrifice. Values
represent the meas ± SE from N mice.
Significatly diferent from the control group, p<0.05. The statistical tests were an ANOVA followed by Tukey's multiple comparison.
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crease in the extent of necrosis caused by a compound
thatis metabolized to an organic free radical (i.e., CC14)
(26). Therefore, the additive relationship is consistent
with available data concerning the biochemical effects
ofthese compounds.
The toxicologic relationship between 1,3-DCP and
CC14 is clearly one that is less than additive. This con-
clusion is based on three different experimental para-
digms: serum hepatic enzyme, pentane generation, and
histopathology. The information collected by these ex-
perimental designs is not sufficient to determine the
mechanism by which 1,3-DCP interferes with the
expression of CC14 toxicity. However, without the "le-
thal cleavage" of chlorine to form the trichloromethyl
radical (27), CCl4 may not cause its characteristic tox-
icological changes. Although one might expect that 1,3-
DCP destroys cytochrome P-450, the data in Table 4
show that 1,3-DCP does not destroy the cytochrome P-
450 complex. There are several possibilities for where
the interference could be occurring: the absorption of
CC14 could be reduced; there could be competitive in-
hibition for the mixed-function oxidase system; there
may be a shift in CCl4 metabolism; and/or there may be
increased scavaging of free radicals that are formed
after homolytic cleavage of one of the chlorine substi-
tuents in the parent compound. A variety of experi-
mentsneedtobecompletedbeforedefinitive statements
can be made about the locus ofinterference.
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